Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
For newcomers, both BTC and ETH offer accessible entry points, but their ecosystems differ. This guide helps beginners choose where to start.
21,796 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Lucid Group has faced years of volatility, but Saudi backing and a clearer product roadmap could shift the odds. This...
Despite fintech rivals, Western Union remains a durable money-movement platform with a vast network and steady cash f...
When high-profile investors tilt toward value, curious readers take note. This piece breaks down why billionaire Bill...
NuScale Power has seen wild swings, but the story isn’t just nostalgia for a boom. This piece breaks down the odds of...
A straightforward, discipline-driven strategy suggests buying three Vanguard index funds to potentially outperform th...
When you turn 73, the game changes: you must take a required minimum distribution (RMD). This article weighs the pros...
Barrick mining stock sinking this week is a reminder that miners ride metal prices as much as earnings. Here’s what’s...
Nu Holdings faced a sharp February drop as U.S. expansion uncertainty and broader macro headwinds collided with stron...
Institutional investors are quietly reshaping the landscape of net-lease REITs. A notable stake in Agree Realty signa...
Kyntra Bio (KYNB) is on investors' radar as 2025 earnings wrap up. This guide breaks down what the Q4 results mean, h...
Oracle is sitting on a massive backlog that could redefine its AI trajectory in 2026. This deep dive breaks down what...